These are people with RRMS where the disease is very active, the most effective medicines don’t work and they get worse in a short time. Rianne Wisgerhof, director of the National MS Fund: “We are very pleased that this step has been taken. Many congratulations to everyone who worked hard for this.”
international study
Wisgerhof continues: “This is good news for a very small group of people with MS. As the National MS Fund, we therefore invest in RAM-MS research, an international study into the question of whether more people may be eligible for long-term stem cell therapy. So that in some cases one does not opt for the current highly effective drug, but for stem cell therapy at an earlier time. Evidence of this must come from this research.” The MS Research Foundation also invests in this research.
Neurologist Joep Killestein, who is leading the RAM-MS study with his colleagues, recently spoke on National MS Day about how hard he and other neurologists are trying to make stem cell transplantation possible in the Netherlands. This paid off. Read the entire message from the Istituto Superiore di Sanità here.
EenVandaag also paid attention to this news. Read the article here and view the various reactions.
Looking back: Joost Smolders and Joep Killestein
On National MS Day, neurologists Joost Smolders and Joep Killestein answered questions about stem cell therapy. They also gave clear explanations about this treatment method. You can the session look back here.
